COVID-19 Risks for Pharma Commercialization

In this ISSUE

Transforming the CIO Role to Embrace Digital Health

Doubling Down on D&I

Payer Perspectives on Gene Therapy Reimbursement

Telehealth

How COVID-19 is Forcing Pharma to Adopt New Physician Interaction Models

Over the coming months, HCPs and manufacturers will experiment with different approaches to e-detailing, in order to arrive at an approach that works for everyone, writes Scott Morano.
... /Read more/

Patient Experience Breakthroughs: Leveraging the Latest Digital Tools and Techniques to Optimize your Patient Experience Goals
Tuesday, May 19, 2020 at 1pm EDT | 12pm CDT | 10am PDT
Register now

Commercialization

COVID-19: Risks for Pharma Commercialization

COVID-19: Risks for Pharma Commercialization
... /Read more/

Using Big Data to Build Excellent Forecasts
Wednesday, June 24, 2020 at 11am EDT
Register now

Q&A

Commercial Strategy under COVID-19

Grünenthal's Florent Edouard and Veeva's Jan van den Burg talks about how the COVID-19 pandemic is changing the way the industry reaches and engages with its customers.
... /Read more/

Accelerate Launch Readiness – Strategies to Stay Ahead of the Curve
Wednesday, May 20, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now

Calendar

/ DIA 2020 Global Annual Meeting — 6/14-6/18 /

/ BePharma 2020 — 6/15-6/17 /

/ Patient Support Services Congress— 6/16-6/18 /

Three Necessary Steps When Designing your New World Protocol
Thursday, May 21, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
Register Now

Annual Feature

HBA's Woman of the Year 2020: A Motivated Mission

For Sandra Horning, this year's Healthcare Businesswomen’s Association Woman of the Year, harnessing the patient experience has been the driving force in a career-spanning mission to fight disease and accelerate the delivery of new medicines.
... /Read more/

Pharmaceutical Executive Announces its 2020 Emerging Pharma Leaders
Wednesday, May 13, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
Register now

The Pharm Exec Podcast: Episode 55

Developing a Maternal RSV Vaccine

Kathrin Jansen, Senior Vice President and Head of Vaccine Research and Development at Pfizer, talks about the challenges of creating a new maternal vaccine for respiratory syncytial virus, also known as RSV, currently being administered to pregnant women in trials, in the hopes of protecting their infants.
... /Read more/

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com